Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Stocks slump in August kick-off as data reignites slowdown worries



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Stocks slump in August kick-off as data reignites slowdown worries</title></head><body>

US manufacturing gauge drops to eight-month low

Arm Holdings down after tepid Q2 revenue forecast

Eli Lilly up as weight-loss drug cut heart failure risk in trial

Indexes down: Dow 1.21%, S&P 500 1.37%, Nasdaq 2.3%

Updated at 4:09 p.m. ET/2009 GMT

By Chuck Mikolajczak

NEW YORK, Aug 1 (Reuters) - U.S. stocks kicked off August sharply lower after a round of economic data on Thursday spurred concerns the economy may be slowing faster than anticipated while the Federal Reserve maintains a restrictive monetary policy.

Equities initially opened higher, buoyed in part by gains in Meta PlatformsMETA.O after its quarterly resultstopped expectations and the Facebook parent issued an upbeat outlook for the third quarter. Its shares closed 5.87% higher as the biggest boost to the S&P 500.

Early gains, however, evaporated after data showed a measure of manufacturing activity from the Institute for Supply Management (ISM) dropped to an eight-month low in July at 46.8, signifying contraction.

"It raises a genuine fear that the Fed is behind on cutting rates," Lou Basenese, president and chief market strategist at MDB Capital in New York.

"Few investors have confidence in the Fed sticking the proverbial soft landing and now the data is starting to support those concerns."

The Dow Jones Industrial Average .DJI fell 494.82 points, or 1.21%, to 40,347.97, the S&P 500 .SPX lost 75.62 points, or 1.37%, to 5,446.68 and the Nasdaq Composite .IXIC lost 405.25 points, or 2.30%, to 17,194.15.

August is typically one of the weakest months of the year for stocks.

Other data showed the number of Americans filing new applications for unemployment benefits increased to an 11-month high last week, suggesting some softening in the labor market, although seasonal factors also played a role.

Investors will eye the government payrolls report on Friday for any signs of further weakness in the labor market.

Both the S&P 500 and Nasdaq registered their biggest daily percentage gains since February in the prior session, boosted by a rally in chip shares after the Fed kept rates steady, as expected.

Defensive sectors such as utilities.SPLRCU and real estate.SPLRCR led gains, as geopolitical concerns over rising tensions in the Middle Eastboosted the dollar and pulled Treasuryyields lower.

Declines in megacap names such as AppleAAPL.O, down 1.68%, and AmazonAMZN.O, which lost 1.56% ahead of their quarterly results due after the closing bell weighed heavily on the tech .SPLRCT and consumer discretionary .SPLRCD indexes, which were among the worst performing of the 11 major S&P sectors.

After the closing bell, Amazon shares lost 4.47% following its quarterly results and outlook .

Of the 342 companies in the S&P 500 that have reported earnings through Thursday morning, 79.2% have topped analyst expectations, according to LSEG data, slightly above the 79% beat rate over the past four quarters. The estimated earnings growth rate for the quarter is 13.3%, up from 10.6% on July 1.

The small-cap Russell 2000 .RUT slumped 3.03% for its biggest daily percentage drop since Feb. 13. Small caps have been volatile recently as investors rotate between cheaper names and more expensive stocks.

"Without a good economy, these economically sensitive small stocks just won’t do anything, even with rate cuts," said Steve Sosnick, market strategist Interactive Brokers, Greenwich, Connecticut.

Nvidia NVDA.O dropped 6.67% in a broader chip stocks selloff sparked byArm Holdings' ARM.O conservative revenue forecast and Qualcomm QCOM.O flagging a revenue hit from the impact of trade curbs. ARM shares plummeted 15.72% while Qualcomm stumbled 9.37% as the PHLX semiconductor index .SOX lost 7.14% for its biggest daily percentage drop since March 2020.

Moderna MRNA.O plunged 21.01% after cutting its 2024 sales forecast for COVID-19 and respiratory syncytial virus vaccines by up to 25%.

Eli Lilly LLY.Nrose 3.5% aftertrial results showed weight-loss drug Zepbound reduces the risk of hospitalization, death and other outcomes for obese adults with a common type of heart failure.

Declining issues outnumbered advancers by a 2.04-to-1 ratio on the NYSE and on the Nasdaq, declining issues outnumbered advancers by a 3.19-to-1 ratio.

The S&P 500 posted 54 new 52-week highs and seven new lows while the Nasdaq Composite recorded 65 new highs and 177 new lows.

Volume on U.S. exchanges was 14.15 billion shares, compared with the 11.71 billion average for the full session over the last 20 trading days.



US unemployment claims https://reut.rs/3yqdYFJ

Q2 earnings growth on track for most S&P 500 sectors Q2 earnings growth on track for most S&P 500 sectors https://reut.rs/3Sv5ZOz


Reporting by Chuck Mikolajczak, additional reporting by Chibuike Oguh and Suzanne McGee; Editing by Marguerita Choy

</body></html>

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.